Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Coumarin heterozygous pyridone compounds having iron chelation and monoamine oxidase B inhibitory activity as well as preparation and application of compounds

A technology of pyridone and coumarin, applied in the direction of organic active ingredients, organic chemistry, medical preparations containing active ingredients, etc., can solve the problem of increasing neurotransmitters in the brain

Active Publication Date: 2019-09-10
ZHEJIANG UNIV OF TECH
View PDF2 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These drugs only act on a single target, prevent neurotransmitter enzymes from metabolizing neurotransmitters and temporarily increase the amount of neurotransmitters in the brain, which cannot fundamentally cure AD, but can only control or improve the cognitive and functional symptoms of patients6- 12 months, delay the progression of the disease
Studies have shown that AD is a disease caused by multiple reasons, so the traditional drug discovery strategy of "finding a target for a disease and developing a class of drugs" is not suitable for AD, a complex disease, multi-target The point drug strategy is considered to be the most effective new method, and there are very few multi-target drugs for AD currently under development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Coumarin heterozygous pyridone compounds having iron chelation and monoamine oxidase B inhibitory activity as well as preparation and application of compounds
  • Coumarin heterozygous pyridone compounds having iron chelation and monoamine oxidase B inhibitory activity as well as preparation and application of compounds
  • Coumarin heterozygous pyridone compounds having iron chelation and monoamine oxidase B inhibitory activity as well as preparation and application of compounds

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0058] 2-Methyl-3-hydroxy-1-((coumarin-3-yl)methyl)pyridin-4(1H)-one (1a)

[0059] Add maltol (7.56g, 60mmol), acetone 100mL, and methyl iodide (9.37g, 66mmol) into a 250mL single-necked bottle, heat and reflux for 6 hours, cool to room temperature after the reaction, spin to dry the solvent, add 100mL water to dissolve, and Methyl chloride (50 mL) was extracted 4 times, the organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated to obtain 2-methyl-3-methoxypyrone. Yield 98%.

[0060] Add the pyrone (8.65g, 40mmol) obtained by the above reaction into a 250mL one-mouth bottle, 60mL of 25% ammonia water, 50mL of ethanol, heat and reflux at 75°C for 12h, cool to room temperature after the reaction is completed, spin the solvent to obtain a brown oily liquid, and use Acetone / ethyl acetate recrystallization gave 2-methyl-3-methoxypyridone as a light yellow solid. Yield 75%.

[0061] Add salicylaldehyde (7.33g, 60mmol), propionic anhydride (3...

Embodiment 2

[0070] The preparation method of 2-methyl-3-hydroxyl-1-((7-methoxy-coumarin-3-yl)methyl)pyridin-4(1H)-one (1b)

[0071]

[0072]Add maltol (7.56g, 60mmol), acetone 100mL, and methyl iodide (9.37g, 66mmol) into a 250mL single-necked bottle, heat and reflux for 6 hours, cool to room temperature after the reaction, spin to dry the solvent, add 100mL water to dissolve, and Methyl chloride (50 mL) was extracted 4 times, the organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated to obtain 2-methyl-3-methoxypyrone. Yield 98%.

[0073] Add the pyrone (8.65g, 40mmol) obtained by the above reaction into a 250mL one-mouth bottle, 60mL of 25% ammonia water, 50mL of ethanol, heat and reflux at 75°C for 12h, cool to room temperature after the reaction is completed, spin the solvent to obtain a brown oily liquid, and use Acetone / ethyl acetate recrystallization gave 2-methyl-3-methoxypyridone as a light yellow solid. Yield 75%.

[0074] Add 2-hydro...

Embodiment 3

[0082] The preparation method of 2-methyl-3-hydroxyl-1-((7-propargyloxy-coumarin-3-yl)methyl)pyridin-4(1H)-one (1c)

[0083]

[0084] Add maltol (7.56g, 60mmol), acetone 100mL, and benzyl bromide (11.29g, 66mmol) into a 250mL single-necked bottle, heat and reflux for 6 hours, cool to room temperature after the reaction, spin the solvent, add 100mL water to dissolve, and Methyl chloride (50 mL) was extracted 4 times, the organic layer was dried over anhydrous sodium sulfate, and the organic layer was concentrated to obtain 2-methyl-3-benzyloxypyrone. Yield 98%.

[0085] Add the pyrone (8.65g, 40mmol) obtained by the above reaction into a 250mL one-mouth bottle, 60mL of 25% ammonia water, 50mL of ethanol, heat and reflux at 75°C for 12h, cool to room temperature after the reaction is completed, spin the solvent to obtain a brown oily liquid, and use Acetone / ethyl acetate recrystallization gave 2-methyl-3-benzyloxypyridone as a light yellow solid. Yield 75%.

[0086] Add 2,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses coumarin / pyridone heterozygous derivatives represented by a formula (I) shown in the description or a pharmaceutically-acceptable salt of the derivatives. The preparation method of the coumarin / pyridone heterozygous derivatives comprises the following steps: one pyridone derivative represented by a formula 3 shown in the description is obtained by a series of synthesis by using one hydroxypyrone with different substituent groups represented by a formula 1 shown in the description as a raw material; and a compound represented by a formula 4 shown in the description is subjected to a condensation reaction to obtain a compound represented by a formula 5 shown in the description, one-step bromination is performed to obtain a compound represented by a formula 6 shown inthe description, the compound represented by the formula 6 and the pyridone derivative represented by the formula 3 are subjected to a one-step nucleophilic substitution reaction to obtain a compoundrepresented by a formula 7 shown in the description, and finally an alkyl protecting group in a pyridone structure is removed to obtain one target compound represented by the formula (I). The compounds provided by the invention are a novel series of single-molecular multi-target series drugs, and have iron chelation, targeted MAO-B inhibitory activity, antioxidant activity, unique advantages for an Alzheimer disease with complicated pathogenesis, a clear mechanism of action and excellent activity.

Description

technical field [0001] The invention relates to the fields of organic synthesis and medicinal chemistry, in particular to a class of coumarin hybrid pyridone compounds with monoamine oxidase B inhibitory effect and metal iron ion chelating ability and antioxidant activity and its preparation method and anti-Alzheimer's effect. use in mutism. Background technique [0002] Alzheimer's disease (AD) is a neurodegenerative disease with insidious onset, complex etiology, and progressive development. The clinical manifestations are persistent mental decline, aphasia, loss of judgment ability, and movement disorders. AD patients will cause a heavy economic and nursing burden to the family and the society. There are only five drugs currently on the market and used clinically: Donepezil, Rivastigmine, Galantamine, and Tacrine, four acetylcholinesterase inhibitors (AChEi). ), and the N-methyl-D-aspartate receptor (NMDA) inhibitor Memantine. These drugs only act on a single target, p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D405/06A61K31/4433A61P25/28A61P25/16A61P39/04
CPCA61P25/16A61P25/28A61P39/04C07D405/06Y02P20/55
Inventor 谢媛媛张长俊袁圣利韩家鑫米治胜蒋筱莹
Owner ZHEJIANG UNIV OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com